IXC
INVEX Therapeutics Ltd
- Announcements, last 12 months
- 23
- Price sensitive, last 12 months
- 10
- Followed on InvestorPA
- Low (Outside the 20% most-followed companies on InvestorPA)
Latest announcements
Sign in to see all IXC announcements.
Guidance history
| 23 Jul 2026 | Operating cash outflows for Q4 FY26 were $501,000 |
Most followed in Health Care
Follow IXC to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in